October 29, 2024
Entrepreneurship
Shalabh Gupta, MD, founder and CEO of Unicycive Therapeutics, shares his journey of taking his biotech company public with just one employee. Gupta discusses the strategic decisions behind this bold move, the challenges of scaling a biotech company, and why building a strong, cohesive team may be the key to long-term success in the biotech industry.
For this week’s Tuesday Talks as Shalabh Gupta, MD, founder and CEO of Unicycive Therapeutics, delves into the remarkable story of how he took his biotech startup public with just one employee. Gupta reveals the pivotal decisions behind this bold move, explore the challenges of scaling a biotech company, and share his insights on why a strong team can be the cornerstone of long-term success in the biotech field.
Shalabh Gupta, MD, CEO and founder of Unicycive Therapeutics, is on a mission to revolutionize kidney disease care by changing drug formulation to address the overwhelming number of daily pills patients must take.
